Literature DB >> 9398803

Effects of somatostatin (SMS) on pancreatic microcirculation.

T Plusczyk1, D Rathgeb, S Westermann, G Feifel.   

Abstract

The effect of bolus infusion of increasing somatostatin (SMS) concentrations (1, 10, 100, 200 micrograms/100 g body wt) on pancreatic microcirculation and pancreatic tissue PO2 were investigated by using in vivo epifluorescence microscopy and a polarographic PO2 measurement technique. Additionally, the microperfusion of the pancreas, liver, spleen, stomach, and duodenum was measured by a laser Doppler device. Bolus infusion of SMS caused a significant, transient, and dose-dependent decrease in pancreatic capillary RBC velocities (to 50% of baseline) and acinar capillary overall perfusion (to 20% of baseline), which was not caused by a macrocirculatory depression. This pronounced decrease in microperfusion was not paralleled by a decline in tissue PO2. Laser Doppler measurements revealed that pancreatic and gastric microperfusion were reduced only at maximal SMS concentrations, considering that microperfusion of the liver, spleen, and duodenum was not altered. Therefore, we found further evidence that circulatory adjustment might occur during SMS inhibited secretory activity of the exocrine pancreas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398803     DOI: 10.1023/a:1018862616845

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Circulatory effects of somatostatin in anesthetized man.

Authors:  G Tydén; H Samnegård; L Thulin; O Muhrbeck; S Efendić
Journal:  Acta Chir Scand       Date:  1979

2.  Quantitation of the hepatic arterial buffer response to graded changes in portal blood flow.

Authors:  W W Lautt; D J Legare; W R Ezzat
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

3.  Intravenous and subcutaneous administration of a long-acting somatostatin analogue: effects on glucose metabolism and splanchnic haemodynamics in healthy subjects.

Authors:  L S Eriksson; J Wahren
Journal:  Eur J Clin Invest       Date:  1989-04       Impact factor: 4.686

4.  Microscopy of the living pancreas in situ.

Authors:  R S McCuskey; T M Chapman
Journal:  Am J Anat       Date:  1969-12

5.  The effect of somatostatin analogue (SMS 201-995) on pancreatic blood flow.

Authors:  D R Conway; G Djuricin; R A Prinz
Journal:  Surgery       Date:  1988-12       Impact factor: 3.982

6.  Hemorrhagic hypotension induces arteriolar vasomotion and intermittent capillary perfusion in rat pancreas.

Authors:  B Vollmar; G Preissler; M D Menger
Journal:  Am J Physiol       Date:  1994-11

7.  Systemic and regional hemodynamics of isoflurane and sevoflurane in rats.

Authors:  P F Conzen; B Vollmar; H Habazettl; E J Frink; K Peter; K Messmer
Journal:  Anesth Analg       Date:  1992-01       Impact factor: 5.108

8.  Blood flow and tissue oxygen pressures of liver and pancreas in rats: effects of volatile anesthetics and of hemorrhage.

Authors:  B Vollmar; P F Conzen; T Kerner; H Habazettl; M Vierl; H Waldner; K Peter
Journal:  Anesth Analg       Date:  1992-09       Impact factor: 5.108

9.  Effect of exogenous somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog.

Authors:  B A Price; B M Jaffe; M J Zinner
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

Review 10.  Octreotide, a new somatostatin analogue.

Authors:  M D Katz; B L Erstad
Journal:  Clin Pharm       Date:  1989-04
View more
  2 in total

1.  Differential effects of ET-1, ET-2, and ET-3 on pancreatic microcirculation, tissue integrity, and inflammation.

Authors:  T Plusczyk; B Bersal; M D Menger; G Feifel
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

2.  Somatostatin attenuates microcirculatory impairment in acute sodium taurocholate-induced pancreatitis.

Authors:  T Plusczyk; D Rathgeb; S Westermann; G Feifel
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.